← Back to Search

Behavioral Intervention

Mindfulness for Stress and ADHD

N/A
Recruiting
Led By Nancy L. Heath, Ph.D.
Research Sponsored by McGill University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks 1, 6, 10, and 18
Awards & highlights

Study Summary

This trial will study uni students with stress, ADHD, or NSSI to see if mindfulness instruction helps. It will compare formal & informal mindfulness & a control group.

Who is the study for?
This trial is for McGill or Concordia University students aged 18-29 who self-report stress, ADHD, or have a history of non-suicidal self-injury (NSSI) on at least five different days in the past year. It's not open to those whose NSSI doesn't meet specific recent and frequent criteria.Check my eligibility
What is being tested?
The study compares two types of mindfulness programs: formal and informal instruction, over four weeks. Participants will be randomly assigned to one of these programs or a control group without any intervention to see which is more acceptable and effective.See study design
What are the potential side effects?
Mindfulness practices are generally considered safe but may sometimes lead to increased anxiety, emotional discomfort, or distraction during initial practice as individuals become more aware of their thoughts and feelings.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks 1, 6, 10, and 18
This trial's timeline: 3 weeks for screening, Varies for treatment, and weeks 1, 6, 10, and 18 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dispositional mindfulness
Secondary outcome measures
Academic engagement
Acceptability (as measured by the IMI)
Acceptability (as measured by the TFA questionnaire)
+4 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Informal mindfulness instructionExperimental Treatment1 Intervention
Group II: Formal mindfulness instructionExperimental Treatment1 Intervention
Group III: Inactive controlActive Control1 Intervention
An equal number of university students from all groups will participate in this arm (i.e., those with ADHD, those with a history of nonsuicidal self-injury, and those with self-reported stress). Participants assigned to the inactive control condition will not complete any tasks during the four-week intervention period.

Find a Location

Who is running the clinical trial?

McGill UniversityLead Sponsor
395 Previous Clinical Trials
999,017 Total Patients Enrolled
2 Trials studying Mindfulness
528 Patients Enrolled for Mindfulness
Concordia University, MontrealOTHER
22 Previous Clinical Trials
4,307 Total Patients Enrolled
University of OttawaOTHER
207 Previous Clinical Trials
266,781 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research include elderly participants above the age of 70?

"The current criteria stipulates that only patients aged 18 to 29 can partake in this trial. Conversely, there are 280 trials specifically for people under the legal age of consent and 696 studies for those over 65 years old."

Answered by AI

Are individuals presently being welcomed into this research endeavor?

"Based on information gathered from clinicaltrials.gov, this trial is currently recruiting participants. The initial post was made on September 6th 2023 and the details have been revised as recently as September 8th of that same year."

Answered by AI

Am I eligible to partake in this clinical trial?

"Applicants to this medical trial must possess mindfulness and be between 18-29 years of age. The total number of potential participants is 360 people."

Answered by AI

How many individuals are volunteering for this medical experiment?

"Affirmative. Clinicaltrials.gov reveals that this clinical trial, initiated on September 6th 2023, is actively recruiting participants. As such, they require 360 patients across two sites to take part in the research."

Answered by AI
~45 spots leftby Jun 2024